Skip to content

Gynecologic Extramammary Paget's Disease

Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03564483
Enrollment
100
Registered
2018-06-20
Start date
2018-02-19
Completion date
2050-12-01
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extramammary Paget Disease, Extramammary Paget's Disease, Extramammary Paget's Disease of Anal Canal (Diagnosis), Extramammary Paget's Disease of Anus (Diagnosis), Extramammary Paget's Disease of Skin, Extramammary Paget's Disease of Vagina (Diagnosis), Extramammary Paget's Disease of Vulva (Diagnosis), Extramammary Paget's Disease Vulva Invasive, Paget Disease, Extramammary

Brief summary

In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

Detailed description

This is a prospective cohort study. Patients with Extramammary Paget's Disease (EMPD), specifically women with vulvar/perianal Paget's disease, will be identified during presentation to either the Dermatology Department or Gynecologic Surgery department at Mayo Clinic. During physical exam, the patients will undergo skin/rectum/vagina cultures to evaluate the microbiome in these patients. The patients will be entered into the established care pathway for EMPD. They will be asked to complete sexual health questionnaires including: The Women's Health Clinical Questionnaires include the Menopause Rating Scale (MRS)1, Perceived Stress Scale2, Brief Resilience Scale (BRS)3, LASA Quality of Life Assessment4, Female Sexual Function Index (FSFI)5, Female Sexual Distress Scale-Revised6, Kansas Marital Satisfaction Scale7, and Pittsburgh Sleep Quality Index (PSQI)8. The patients will be referred to Women's Health Clinic as part of the care pathway and will undergo preoperative genital sensory testing (GST) which measures sensation of the clitoris, vulva, and vagina. The patients will have a Dermatology consultation and Moh's micrographic procedure as indicated. If choosing to proceed with surgical intervention, the patients will then undergo an excisional procedure with the Department of Gynecologic surgery. Swabs, urine and tissue will be collected prior to procedures or surgery for microbiome analysis.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females * Age 18 years or older * Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body * Willing and able to provide signed informed consent

Exclusion criteria

* Males * Diagnosis of Paget's Disease in body areas other than vulvar or perianal region

Design outcomes

Primary

MeasureTime frameDescription
Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD).25 yearsProspective data including patient demographic information, surgical outcomes, surgical morbidity, recurrence, and long-term survival in extramammary Paget's disease (EMPD) will be collected as part of this registry..

Countries

United States

Contacts

CONTACTMaureen A. Lemens, R.N.
lemens.maureen@mayo.edu507-293-1487
CONTACTKaren P Ishitani, RN
ishitani.karen@mayo.edu507-538-5355
PRINCIPAL_INVESTIGATORJamie N. Bakkum-Gamez, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026